Related stories
Eli Lilly Reports Retatrutide Reduced Knee Osteoarthritis Pain in Phase 3 Study
Eli Lilly reported that retatrutide reduced knee osteoarthritis pain in a Phase 3 study.
M impact | EQUITY | Nov 05, 2026, 11:50 AM UTC
Becton Dickinson Fiscal Q4 Earnings Snapshot
M impact | EQUITY | Nov 05, 2026, 11:50 AM UTC
Tapestry Sees Q2 Revenue Growth of About 5% to 6%
Tapestry expects second-quarter revenue to grow about 5% to 6% year over year on a constant-currency basis.
M impact | EQUITY | Nov 05, 2026, 11:50 AM UTC
Cohere CEO Says IPO Timing Remains Uncertain Despite Revenue Growth
Cohere’s chief executive said the Canadian AI company’s timeline for going public remains uncertain. The company’s revenue is described as surging.
M impact | EQUITY | Nov 05, 2026, 11:49 AM UTC
Lu Hai Holding Reports Third-Quarter Net Profit of NT$49.6 Million
Lu Hai Holding reported third-quarter net profit of NT$49.6 million, versus NT$24.9 million a year earlier. Revenue was NT$978.192 million, compared with NT$692.636 million, and pr
M impact | EQUITY | Nov 05, 2026, 11:49 AM UTC
Himax Reports Q3 2026 Results and Issues Q4 Guidance
Q3 2026 EPS exceeded guidance, while revenue and gross margin were in line with guidance issued Aug. 6, 2026.
M impact | EQUITY | Nov 05, 2026, 11:49 AM UTC